STOCK TITAN

Pacira BioSciences (PCRX) director receives new RSUs and stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Pacira BioSciences director Samit Hirawat received new equity awards. He was granted 6,405 restricted stock units of common stock, which will vest on June 10, 2027 if he remains in continuous service with the company through that date.

He was also granted stock options covering 10,891 shares of common stock at an exercise price of $23.42 per share. These options vest and become exercisable on June 10, 2027, and expire on June 10, 2036. Following these awards, he holds 6,405 common shares and options on 10,891 shares directly.

Positive

  • None.

Negative

  • None.
Insider Hirawat Samit
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 10,891 $0.00 --
Grant/Award Common Stock 6,405 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 10,891 shares (Direct, null); Common Stock — 6,405 shares (Direct, null)
Footnotes (1)
  1. Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date.
RSUs granted 6,405 units Restricted stock units vesting June 10, 2027
Stock options granted 10,891 options Right to buy common stock
Option exercise price $23.42 per share Conversion or exercise price
RSU vesting date June 10, 2027 Requires continuous service to vest
Option vesting date June 10, 2027 Date options become exercisable
Option expiration June 10, 2036 Final expiration date for the options
Shares held after grant 6,405 shares Total common stock directly owned after RSU grant
Underlying option shares 10,891 shares Common shares subject to the new option
restricted stock units financial
"Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
stock option financial
"The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "23.4200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
continuous service financial
"provided that the reporting person remains in continuous service with the issuer through the vesting date"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hirawat Samit

(Last)(First)(Middle)
C/O PACIRA BIOSCIENCES, INC.
2000 SIERRA POINT PARKWAY, SUITE 900

(Street)
BRISBANE CALIFORNIA 94005

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Pacira BioSciences, Inc. [ PCRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/10/2026A6,405(1)A$06,405D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$23.4206/10/2026A10,89106/10/2027(2)06/10/2036Common Stock10,891$010,891D
Explanation of Responses:
1. Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
2. The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date.
Remarks:
/s/ Kristen Williams, Attorney-in-Fact06/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Pacira BioSciences (PCRX) director Samit Hirawat receive?

Samit Hirawat received 6,405 restricted stock units and stock options on 10,891 Pacira BioSciences common shares. The RSUs and options were granted at no cost as compensation and are subject to future vesting conditions tied to his continued service.

When do Samit Hirawat’s new Pacira (PCRX) restricted stock units vest?

The 6,405 restricted stock units vest on June 10, 2027, if Hirawat remains in continuous service with Pacira BioSciences until that date. Each vested unit will convert into one share of the company’s common stock once the vesting condition is satisfied.

What are the terms of Samit Hirawat’s new Pacira (PCRX) stock options?

Hirawat’s new stock options cover 10,891 Pacira BioSciences common shares at an exercise price of $23.42 per share. The options vest and become exercisable on June 10, 2027, and will expire on June 10, 2036, if not exercised earlier.

Are Samit Hirawat’s Pacira (PCRX) equity awards tied to his continued service?

Yes. Both the 6,405 restricted stock units and the 10,891-share stock option grant require Hirawat to remain in continuous service with Pacira BioSciences through June 10, 2027. Vesting and exercisability depend on this ongoing service condition being met.

How many Pacira (PCRX) shares does Samit Hirawat hold after these grants?

After the grants, Hirawat directly holds 6,405 shares of Pacira BioSciences common stock and stock options covering an additional 10,891 shares. These holdings reflect the new awards reported and show his current direct equity position from this filing.